Ira Zackon, MD, discusses the real-world uptake of bispecific antibodies in community oncology practices and what it reveals about their utilization in relapsed/refractory multiple myeloma treatment.
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, ...
Analysts estimate that ImmunoPrecise Antibodies will report an earnings per share (EPS) of $-0.07. Investors in ImmunoPrecise Antibodies are eagerly awaiting the company's announcement, hoping for ...